Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2018 (2018), Article ID 4064369, 7 pages
Clinical Study

Comparison of Two Toric IOLs with Different Haptic Design: Optical Quality after 1 Year

1Department of Ophthalmology, Hospital Hietzing, Vienna, Austria
2Karl Landsteiner Institute of Process Optimization and QM in Cataract Surgery, Vienna, Austria

Correspondence should be addressed to Kata Miháltz

Received 8 September 2017; Revised 10 November 2017; Accepted 20 November 2017; Published 11 February 2018

Academic Editor: David P. Piñero

Copyright © 2018 Kata Miháltz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. The purpose of this prospective, randomised study was to interocularly compare the visual performance after implantation of two different toric IOLs with different haptic design. Methods. 59 subjects with corneal astigmatism greater than 1.25 diopter (D) were implanted with an AT TORBI 709M IOL (Carl Zeiss Meditec AG) in one eye and with a Tecnis toric aspheric IOL (Abbot Medical Optics) in the other eye. Observation procedure was performed 12 months postoperatively. Main outcome measures included uncorrected distance visual acuity (UDVA), manifest refraction, IOL rotation, and IOL position. Results. Mean UCDVA was 0.04 ± 0.14 logMAR for AT TORBI eyes and 0.06 ± 0.15 logMAR for Tecnis eyes (). The postoperative spherical equivalent values were significantly lower in the AT TORBI group. Mean toric IOL axis rotation was 3.0 ± 2.26 degrees for AT TORBI eyes and 3.27 ± 2.37 for Tecnis eyes (). The mean vertical IOL tilt and vertical decentration values measured with the Visante OCT were significantly larger in the AT TORBI group (). Conclusions. Both the Tecnis and the AT TORBI toric IOLs successfully reduced ocular astigmatism. Emmetropia could be better achieved with the AT TORBI IOL, whereas the Tecnis showed better positional stability. This trial is registered with ICMJE NCT03371576.